ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

19.91
Delayed Data
As of 4:00pm ET
 +1.01 / +5.34%
Today’s Change
15.68
Today|||52-Week Range
57.34
-62.76%
Year-to-Date

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 25.00, with a high estimate of 35.00 and a low estimate of 18.00. The median estimate represents a +25.57% increase from the last price of 19.91.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Hold stock in ACADIA Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.24
Sales
$135.4M
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -163.81%
 
 
 
 
 
 
Growthannually 43.07%
 
 
 
 
 
 

Sales

Growthquarterly 2.87%
 
 
 
 
 
 
Growthannually 10.46%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.